TruAlt Bioenergy is currently trading at Rs. 466.45, up by 4.65 points or 1.01% from its previous closing of Rs. 461.80 on the BSE.

The scrip opened at Rs. 443.20 and has touched a high and low of Rs. 484.00 and Rs. 434.05 respectively. So far 91931 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 550.00 on 03-Oct-2025 and a 52 week low of Rs. 401.75 on 06-Nov-2025.

Last one week high and low of the scrip stood at Rs. 488.00 and Rs. 401.75 respectively. The current market cap of the company is Rs. 4029.51 crore.

The promoters holding in the company stood at 70.55%, while Institutions and Non-Institutions held 8.38% and 21.07% respectively.

Trualt Bioenergy has entered into a Joint Venture Agreement (JVA) and Share Purchase Agreement (SPA), with Japan-based Sumitomo Corporation, marking a pivotal milestone in accelerating India’s compressed biogas (CBG) ecosystem. The collaboration aims to develop and scale a robust network of commercial CBG plants. The initial phase includes four CBG production facilities, with scope for additional plants as outlined in the Joint Venture Agreement. The business includes the production, sales, and distribution of CBG, along with value-accretive by-products such as fermented organic manure, biogenic CO2, and carbon credits.

By combining TruAlt’s integrated bioenergy expertise with Sumitomo Corporation’s global industrial experience, the partnership strengthens India’s clean energy transition, promotes circular bioeconomy solutions, and lays the foundation for a future-ready sustainable fuel infrastructure.

Trualt Bioenergy is one of India’s largest biofuels producers, having strategically positioned its elves as a prominent and diversified player in the biofuels industry in India, primarily in the production of Ethanol.